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Objectives. The purpose of this study is to determine the early 
and late results of the surgical repair of atrial septal defect in 
adults. 
Background. Progressi\'ely limiting, untreated atrial septal 
defect can lead to the early death of middle·aged adults. Recently 
it has been suggested that the closure of atrial septal defects might 
be accomplished with inter\'entional cardiac techniques. Although 
the long· term results of the transcatheter closure are as yet 
unknown, the outcom,e of surgical therapy has been shown to be 
beneficial for almost 40 years. 
Methods. Between 1971 and 1991, 166 consecutiw patients 
underwent surgical repair of a secundum or sinus \'enosus atrial 
septal defect, or both, at the Brigham and Women's Hospital, 
Boston. There were 120 women and 46 men in this group; the 
mean age was 44 years and 58 (35%) of the patients were ;:::50 
years old. The awrage pulmonary to systemic flow ratio was 3.0, 
Atrial septal defect is the most common form of congenital 
heart disease found in adolescents and adults (I). Occurring 
in the mid portion of the septum at or near the fossa ovalis, 
secundum atrial septal defects comprise the majority of 
these defects. The next most common type are sinus veno· 
sus defects, which are located higher on the septal wall and 
are usually associated with partial anomalous pulmonary 
venous return (2). Although these malformations are often 
asymptomatic, if uncorrected, they may lead to premature 
death from congestive heart failure or nonreversible pulmo-
nary hypertension. Surgical correction of these defects has 
been accomplished with excellent results for almost 40 
years. More recently, nonoperative closure of atrial septal 
defects with cardiac catheterization has been introduced, 
and now provides an alternative treatment in some patients 
(3). To provide perspective on the surgical treatment of this 
anomaly, we determined the in-hospital risk and long-term 
outcome of 166 adult patients who underwent surgical cor-
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and 57 patients had a peak systolic pulmonary artery pressure 
>30 mm Hg. 
Results. There were two operath'e deaths (early mortality rate 
1.2%), and 13% ofthe patients had a perioperati\'e complication. 
One hundred fifty·three of the 164 suni\'ors were followed up for 
a mean of 90 months (range 2 to 247). There were eight late deaths 
(late mortality rate 4.9 %) and a late morbidity rate of 12.4 % (in 
most cases due to arrhythmias). The 5- and to·year sur\'i\'al rates 
are 98% and 94%, respectiwly, and the probability of e\·ent·free 
sur\'i\'al (with no morbidity or mortality) at 5 years is 97% and at 
to years is 92%. 
Conclusions. The results indicate that the surgical correction of 
atrial septal defect in adults is safe and efficacious as confirmed by 
20 years of follow·up. 
(J Am Coli CardioI1992;20:1156-9) 
rection of one or more atrial septal defects at the Brigham 
and Women's Hospital. 
, Methods 
Between 1971 and September 1991, 166 consecutive 
patients underwent surgical repair of a secundum or sinus 
venosus atrial septal defect, or both (Table 1). Patients with 
an ostium primum atrial'septal defect were excluded. One 
hundred twenty (72%) of the patients were female and 46 
(28%) were male. The mean age of these patients was 44 
years (range 14 to 78); 58 patients (35%) were >50 years of 
age. Before operation, 88% (145 of 166) were in New York 
Heart Association functional class I or II. Pulmonary artery 
pressures were measured in 119 patients. The peak systolic 
pulmonary artery pressure ranged from 12 to 125 mm Hg 
(mean 35). Fifty·seven patients exhibited peak systolic pul· 
monary artery pressures >30 mm Hg. The ratio of pulmo-
nary to systemic blood flow (QJQs) was calculated in 146 of 
the patients, yielding a mean of3.0. Of 166 patients, 88% had 
normal sinus rhythm:) 1 % )ad atrial fibrillation and 1% had 
complete heart block preoperatively. 
All operations were performed with standard cardiopul· 
monary bypass utilizing bicaval and ascending aorta cannu-
lation. Moderate systemic hypothermia was employed for 
myocardial protection for most cases, and cold potassium 
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Table 1. Patients Undergoing Surgical Repair of Secundum or Sinus Venosus Atrial Septal Defects 
All Mean Age PA Systolic Pressure 
Type of Repair Operative 
Type of Defect Patients MfF (yr) >30 mm Hg S P B Deaths 
Secundum 142 37/105 44 44 115 27 0 
Sinus venosus 2 III 55 2 0 2 0 0 
Sinus venosus + anomalous 10 218 46 3 9 0 0 
pulmonary veins 
Secundum + sinus venosus 5 213 46 3 2 2 0 
Secundum + anomalous 5 312 42 4 0 5 0 0 
pulmonary veins 
Secundum + sinus venosus 2 111 36 0 0 
+ anomalous 
pulmonary veins 
Unless otherwise indicated, data are expressed as number of patients. B = both suture and patch; F = female; M = male; P = pericardial patch; PA = 
pulmonary artery; S = sutures. 
cardioplegia was used when a complicated patch repair was 
required. 
All patient follow-up was conducted between July and 
October 1991, and was performed by questionnaire or tele-
phone interview with the patient or the referring physician, 
or both. Postoperative functional class, cardiac rhythm, 
cause of death, incidence of reoperation and incidence of 
stroke were determined at the time of follow-up. Operative 
mortality was defined as death occurring within 30 days of 
operation or during the same hospital stay. Actuarial prob-
ability of survival to death or complications, or both, was 
examined with the Kaplan-Meier life-table method. 
Results 
At operation a majority (86%) of patients had an isolated 
secundum atrial septal defect (Table 1). The defects were 
closed with either a running nonabsorbable monofilament 
suture or an autologous pericardial patch. The majority of 
the secundum atrial septal defects were repaired by primary 
suture closure (78%), whereas almost all the sinus venous 
defects were closed by pericardial patch (83%). In addition 
to primary atrial septal defect repair, 14 patients underwent 
other cardiac procedures (valve repair in 9 and coronary 
artery bypass grafting in 5). In our other patient clinical 
registries, that is, valve surgery or coronary bypass registry, 
occasional patients had a patent foramen ovale closure, but 
patients who had this procedure were also excluded from 
this analysis. 
There were two operative deaths (early mortality rate 
1.2%; Table 2). One patient died of respiratory failure 
secondary to aspiration pneumonia and the second died as a 
result of undiagnosed fixed pulmonary hypertension. There 
was a 13% incidence rate of perioperative complications. 
The most common complication (seven patients) was a 
significant arrhythmia that required cardioversion or pacing; 
14 other nonfatal complications occurred (Table 2). 
Of the 164 operative survivors, 153 were followed up for 
2 to 247 months (mean 90). One hundred forty-one (92%) of 
these 153 survivors were alive and well at the time of 
follow-up. Three patients underwent reoperation for other 
cardiac procedures (coronary artery bypass grafting in one, 
aortic valve replacement in two), and one patient underwent 
reoperation for a recurrent atrial septal defect 3 months after 
the initial operation. Except for four patients who remained 
in New York Heart Association functional class II, all of the 
patients showed functional improvement after operation as 
measured by functional class. Three patients had a late 
stroke and one patient had a late transient ischemic attack; 
none had permanent neurologic dysfunction as a result of 
these events. Fifteen patients developed late arrhythmias: 
atrial fibrillation in 10 (including the 3 who had a late stroke) 
and complete heart block in 5 (Table 3). Six patients had 
resolution of their preoperative arrhythmias, with conver-
sion to normal sinus rhythm from atrial fibrillation in five and 
from complete heart block in one patient. Eight late deaths 
(late mortality rate 4.9%) occurred between 38 and 238 
(mean 120) months postoperatively as a result of heart 
Table 2. Causes of Early Deaths and Early Complications 
Causes of early death 
Respiratory failure 
Pulmonary hypertension 
Total 
Early complications 
Arrhythmia requiring cardioversion 
Reoperation for bleeding 
Air embolus 
Tamponade 
Congestive heart failure 
CVA 
TIA 
Complete heart block 
Respiratory failure 
Total 
Patients 
(no.) 
2 
6 
5 
2 
2 
2 
21 
CV A = cerebrovascular accident; T1A = transient ischemic attack. 
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Table 3. Causes of Late Death and Late Complications 
Causes of late death 
eVA 
Heart failure 
Respiratory failure 
Myocardial infarction 
Hepatic cirrhosis 
Unknown 
Total 
Late complications 
CVA 
TIA 
Arrhythmias 
Total 
Patients 
(no.) 
2 
2 
1 
1 
8 
3 
15 
19 
Abbreviations as in Table 2. 
failure in two, stroke in two and respiratory failure, myocar-
dial infarction, cirrhosis itnd unknown cause in one case _ 
each (Table 2). Five of these eight late deaths occurred in 
patients who were >50 years old at the time of their 
operation. Preoperative pulmonary hyperte-nsion, as mani-
fested by elevated systolic pulmonary artery pressure, was 
present in five of the patients who died late (four in this 
group were >50 years of age). 
Life-table analysis of the survival for all patients (regard-
less of age, type of atrial septal defect or pulmonary hyper-
tension) undergoing operative repair of their atrial septal 
defect demonstrates a 5-year survival rate of 98% and a 
lO-year survival rate of 94% (Fig. 1). Figure 2 shows survival 
rates in 128 patients in whom pulmonary artery pressures 
were measured. The lO-year survival rate was 99% in 71 
patients with a systolic pulmonary artery pressure 
=:;30 mm Hg, whereas it was 85% in 57 patients with a 
systolic pUlmonary artery pressure >30 mm Hg. 
Figure 1. Actuarial probability of survival for all patients with a 
secundum or a sinus venosus atrial septal defect, or both. 
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Figure 2. The 100year survival rates for 128 patients in whom the 
pulmonary pressure was measured and systolic pulmonary artery 
pressure was >30 mm Hg (dotted line) or =:;30 mm Hg (solid line) 
(p = 0.(02). 
Discussion 
Reports (4,5) have documented that a few patients with 
an atrial septal defect have survived into their 80s. However, 
most patients with an uncorrected defect die in the 4th 
decade; 75% of patients are dead by age 50 years and 90% by 
age 60 (6). It is therefore recommended that adults with an 
atrial septal defect, even those who are asymptomatic, 
undergo correction of the anomaly. The mortality, morbidity 
and long-term results after surgical correction of secundum 
or sinus venosus atrial septal defects, with or without 
correction of an associated partial anomalous pulmonary 
venous return, are important in confirming the efficacy and 
benefits of the procedure. Our series reiterates previous 
reports (7-14) of low early and late mortality rates. When 
these previous studies are analyzed, higher mortality rates 
are seen in elderly patients; therefore, age is thought to be a 
relative contraindication to surgical closure (13). In contrast, 
our two operative deaths occurred in patients who were 26 
and 44 years old, respectively. Another negative risk factor 
has been the presence of severe pulmonary hypertension 
(12-14). One of our two operative deaths was in a patient 
with severe pulmonary vascular disease and patients with 
systolic pulmonary artery pressure >30 mm Hg had a 
significantly higher late mortality rate (Fig. 2). Nevertheless, 
the vast majority of adult patients with severe pulmonary 
artery hypertension have done very well early and late after 
atrial septal defect repair. 
Postoperative arrhythmias. There was a 4% incidence 
rate of early atrial fibrillation; all of these patients were 
successfully treated by cardioversion, and there was only 
one patient with long-term recrudescence of atrial fibrilla-
tion. The nine cases of atrial fibrillation that developed later 
resulted in a 7% incidence rale of new atrial fibrillation at the 
time of follow-up. These rates are significantly lower than 
the 40% incidence rate of new atrial fibrillation seen in 
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long-term survivors of other studies (8,10,11,13). In addi-
tion, 5 of the 17 patients with preoperative atrial fibrillation 
had conversion to sinus rhythm postoperatively, whereas 
the other 12 continued to experience the arrhythmia. Simi-
larly, in a previous report (15), 14 of 16 patients with 
preoperative atrial fibrillation had the same arrhythmia after 
atrial septal defect repair. The one patient who had complete 
heart block in the immediate postoperative period was 
successfully treated with a pacemaker; in five other patients, 
new complete heart block was observed at follow-up. Al-
though arrhythmias are not uncommon in these patients 
because of atrial distension and increased atrial pressure, it 
has also been postulated that they may be induced by 
electrical disturbances that, particularly in repair of sinus 
venosus defects, occur as a result of damage incurred when 
a patch is sutured to the junction of the superior vena cava 
and the right atrium (16). In our series, no patient with patch 
repair of a sinus venosus defect developed arrhythmias or 
heart block, and all of our patients with new arrhythmias had 
undergone suture repair of their defect. 
Nonsurgical treatment. Since the first nonoperative clo-
sure ofa secundum defect in 1976 (17), several patients have 
undergone transcatheter closure of an atrial septal defect 
(18,19). IQ one study, 34 of the 40 patients (mean age 20 
years) who underwent catheterization were found to be 
suitable candidates for closure of the atrial septal defect, and 
31 were followed up for a mean of 13 months. The proce-
dure-related mortality rate was 2.9%. There were two in-
stances of occluder embolization (5.9% incidence rate), and 
three patients developed atrial fibrillation (8.8% incidence 
rate). In 7 of 19 patients studied by postprocedure Doppler 
echocardiography, residual leaks occurred around the oc-
c1uder or through small previously unrecognized defects 
(19). The use of trans esophageal echocardiography has been 
implemented to ensure better occluder placement and may 
improve some of these results (20). The consensus from 
these studies is that the transcatheter devices are not appli-
cable for primum, sinus venosus or noncentral secundum 
atrial septal defects because of the need for a rim of tissue 
around the defect to anchor the occluding device. Also, the 
largest defect that appears amenable to closure with this 
technique is approximately 25 to 30 mm in diameter. 
Conclusions. The surgical correction of atrial septal de-
fects is a safe and effective procedure, as verified by almost 
20 years offollow-up. This procedure extends the length and 
quality of life for patients with an otherwise progressively 
limiting disease. 
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